A new paradigm in molecular recognition? Specific antibody binding to membrane-inserted HIV-1 epitopes

Area of Science:

• Virology
• Immunology
• Structural Biology

Background:

• The human immunodeficiency virus type-1 (HIV-1) gp41 subunit contains a membrane proximal external region (MPER).
• The MPER is adjacent to the transmembrane domain (TMD) and is targeted by broadly neutralizing monoclonal antibodies (mAbs) 4E10 and 2F5.
• This region is implicated in destabilizing the viral envelope during the Env glycoprotein-mediated fusion process.

Purpose of the Study:

• To investigate the role of the MPER in HIV-1 fusion.
• To evaluate the MPER as a target for vaccine design.
• To explore the mechanism of action of anti-MPER antibodies.

Main Methods:

• Review of experimental data on MPER function and antibody binding.
• Analysis of MPER-lipid interactions and antibody epitope accessibility.
• Consideration of lipid composition and MPER sequence modulation.

Main Results:

• Experimental data support the model of MPER insertion into the viral membrane interface.
• Antibodies 4E10 and 2F5 bind to epitopes within the membrane interface.
• In-membrane antibody binding effectively blocks MPER-mediated viral fusion.
• Modulation of lipid composition and MPER sequence affects antibody binding and fusion inhibition.

Conclusions:

• The MPER's insertion into the viral membrane is critical for its fusogenic activity.
• Antibodies targeting the MPER can inhibit HIV-1 fusion by binding within the membrane.
• These findings have implications for developing vaccines targeting the MPER.